Business Description
Cryo-Cell International Inc
NAICS : 621999
SIC : 8099
ISIN : US2288951088
Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | -0.15 | |||||
| Debt-to-Equity | -1.23 | |||||
| Debt-to-EBITDA | -1.14 | |||||
| Interest Coverage | 3.79 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -0.39 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.6 | |||||
| 3-Year EPS without NRI Growth Rate | -26.4 | |||||
| 3-Year FCF Growth Rate | -46.1 | |||||
| 3-Year Book Growth Rate | -55.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1.24 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.55 | |||||
| 9-Day RSI | 33.03 | |||||
| 14-Day RSI | 37.02 | |||||
| 6-1 Month Momentum % | 7.85 | |||||
| 12-1 Month Momentum % | 48.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.61 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 35.04 | |||||
| Days Sales Outstanding | 76.68 | |||||
| Days Payable | 111.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.52 | |||||
| Forward Dividend Yield % | 14.08 | |||||
| 5-Year Yield-on-Cost % | 3.52 | |||||
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | 5.5 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.66 | |||||
| Operating Margin % | 11.3 | |||||
| Net Margin % | -28.04 | |||||
| FCF Margin % | 5.51 | |||||
| ROA % | -14.02 | |||||
| ROIC % | 3.89 | |||||
| 3-Year ROIIC % | -10.6 | |||||
| ROC (Joel Greenblatt) % | -51.53 | |||||
| ROCE % | -25.6 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 88.75 | |||||
| PE Ratio without NRI | 37.97 | |||||
| Shiller PE Ratio | 43.14 | |||||
| PS Ratio | 1.84 | |||||
| Price-to-Free-Cash-Flow | 33.33 | |||||
| Price-to-Operating-Cash-Flow | 8.12 | |||||
| EV-to-EBIT | -5.87 | |||||
| EV-to-EBITDA | -6.49 | |||||
| EV-to-Revenue | 2.1 | |||||
| EV-to-FCF | 38.13 | |||||
| Price-to-Projected-FCF | 11.64 | |||||
| Price-to-Median-PS-Value | 1 | |||||
| Earnings Yield (Greenblatt) % | -17.04 | |||||
| FCF Yield % | 3.06 | |||||
| Forward Rate of Return (Yacktman) % | 5.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cryo-Cell International Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 31.839 | ||
| EPS (TTM) ($) | -1.073 | ||
| Beta | 0.53 | ||
| Volatility % | 59.21 | ||
| 14-Day RSI | 37.02 | ||
| 14-Day ATR ($) | 0.403675 | ||
| 20-Day SMA ($) | 7.68626 | ||
| 12-1 Month Momentum % | 48.16 | ||
| 52-Week Range ($) | 4.475 - 9.498 | ||
| Shares Outstanding (Mil) | 8.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cryo-Cell International Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cryo-Cell International Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cryo-Cell International Inc Frequently Asked Questions
What is Cryo-Cell International Inc(CCEL)'s stock price today?
The current price of CCEL is $7.10. The 52 week high of CCEL is $9.50 and 52 week low is $4.47.
When is next earnings date of Cryo-Cell International Inc(CCEL)?
The next earnings date of Cryo-Cell International Inc(CCEL) is 2025-02-28 Est..
Does Cryo-Cell International Inc(CCEL) pay dividends? If so, how much?
The Dividend Yield %  of Cryo-Cell International Inc(CCEL) is 3.52% (As of Today), Highest Dividend Payout Ratio of Cryo-Cell International Inc(CCEL) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Cryo-Cell International Inc(CCEL) is 14.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers